France To Reimburse For Incontinence

11 May 1997

Some three million people in France suffer from what is described as the"unmentionable" illness of incontinence - still a taboo subject socially.

However, a new law is to be introduced shortly which will enable treatment for the condition to be reimbursed under a payments regime that will apply specifically to dependency among the elderly, and which will be fixed at a percentage of total dependency payments.

Such reimbursements will cover hygiene products and medical treatments in a market estimated to be worth some 1.2 billion French francs ($205.4 million).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight